These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37739041)

  • 21. Review - An update on the use of oral phospholipid excipients.
    van Hoogevest P
    Eur J Pharm Sci; 2017 Oct; 108():1-12. PubMed ID: 28711714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comprehensive Scientific Survey of Excipients Used in Currently Marketed, Therapeutic Biological Drug Products.
    Rao VA; Kim JJ; Patel DS; Rains K; Estoll CR
    Pharm Res; 2020 Sep; 37(10):200. PubMed ID: 32968854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Impact of Surfactant Type and Digestion: Highly Digestible Surfactants Improve Oral Bioavailability of Nilotinib.
    Koehl NJ; Holm R; Kuentz M; Jannin V; Griffin BT
    Mol Pharm; 2020 Sep; 17(9):3202-3213. PubMed ID: 32649208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between Different Pharmaceutical Excipients in Liquid Dosage Forms-Assessment of Cytotoxicity and Antimicrobial Activity.
    Nemes D; Kovács R; Nagy F; Mező M; Poczok N; Ujhelyi Z; Pető Á; Fehér P; Fenyvesi F; Váradi J; Vecsernyés M; Bácskay I
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30041418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
    Abrantes CG; Duarte D; Reis CP
    J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of excipients on oral absorption process according to the different gastrointestinal segments.
    Ruiz-Picazo A; Lozoya-Agullo I; González-Álvarez I; Bermejo M; González-Álvarez M
    Expert Opin Drug Deliv; 2021 Aug; 18(8):1005-1024. PubMed ID: 32842776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
    Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
    Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biopharmaceutical classification system of excipients.
    Vasconcelos T; Marques S; Sarmento B
    Ther Deliv; 2017 Feb; 8(2):65-78. PubMed ID: 28088879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral Absorption Promoters: Opportunities, Issues, and Challenges.
    Yewale C; Patil S; Kolate A; Kore G; Misra A
    Crit Rev Ther Drug Carrier Syst; 2015; 32(5):363-87. PubMed ID: 26559432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines.
    Lo YL
    J Control Release; 2003 Jun; 90(1):37-48. PubMed ID: 12767705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants.
    Allen LV
    Int J Pharm Compd; 2020; 24(5):388-395. PubMed ID: 32886637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
    Miller JM; Beig A; Carr RA; Spence JK; Dahan A
    Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kolliphor surfactants affect solubilization and bioavailability of fenofibrate. Studies of in vitro digestion and absorption in rats.
    Berthelsen R; Holm R; Jacobsen J; Kristensen J; Abrahamsson B; Müllertz A
    Mol Pharm; 2015 Apr; 12(4):1062-71. PubMed ID: 25679417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flux-Based Formulation Development-A Proof of Concept Study.
    Kádár S; Tőzsér P; Nagy B; Farkas A; Nagy ZK; Tsinman O; Tsinman K; Csicsák D; Völgyi G; Takács-Novák K; Borbás E; Sinkó B
    AAPS J; 2022 Jan; 24(1):22. PubMed ID: 34988721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
    Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
    Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical Excipients and Drug Metabolism: A Mini-Review.
    Patel R; Barker J; ElShaer A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral absorption enhancement: taking the next steps in therapeutic delivery.
    Brayden DJ; Maher S
    Ther Deliv; 2010 Jul; 1(1):5-9. PubMed ID: 22816114
    [No Abstract]   [Full Text] [Related]  

  • 40. Improvement of Intranasal Drug Delivery with Intravail
    Rabinowicz AL; Carrazana E; Maggio ET
    Drugs R D; 2021 Dec; 21(4):361-369. PubMed ID: 34435339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.